Matrix metalloproteinases (MMPs), especially MMP2, 3, 9 and 14, derived from cancer-associated fibroblasts (CAFs) and tumour cells, are powerful TME remodelling factors, which enhance tumour invasiveness and metastasis in OSCC [16, 20, 22–24]. Here, MMP2 is linked to neoplasm.